Global e-Prescribing Market will Touch a New Level in Upcoming Year by Key Players: DrFirst, RXNT

BRUSSELS - Oct. 19, 2022 - PRLog -- The Global e-Prescribing Market is set to witness an exponential growth rate of 22% to reach ~US$ 4 billion in the next 5 years. The advantages of e-prescribing (such as enhanced patient safety, reduced prescription and medication errors, instant clinical alerts, prescription fulfillment tracking, etc.), Covid-19, favorable regulatory environment in select countries, accelerated use of telemedicine, growing focus on reducing the abuse of controlled substances, increasing adoption of EHR solutions, government initiatives and incentive programs are some of the main factors propelling the Global e-Prescribing Market. However, limited technology awareness among end-users is likely to hamper the growth of the market.

Covid-19 Triggers Increase in e-Prescribing
Covid-19 harmfully impacted health services internationally and health care providers were forced to change their methods of service delivery. In the wake of the Covid-19 pandemic, e-Prescribing emerged as a significant tool in making a safe environment to avoid the spread of Covid-19, minimizing in-person consultations and paper prescription handling.

Favorable Regulatory Changes Across Countries Provides Impetus to the e-Prescribing Market
The Covid-19 pandemic has made it necessary to alter the e-prescription legislation so that people may quickly and effectively access a variety of healthcare services.

For instance,

• In order to curb the rise in drug-related deaths in the US, the federal government and several states including California, Indiana, Maryland, Michigan, Nebraska, New Hampshire, Utah, and Washington have mandated the e-prescribing of controlled medications in the US. The mandate requires clinical prescribers to write controlled medications electronically.

The original deadline for states to comply with federal EPCS mandates was January 1st, 2021. However, due to complications of COVID-19, the Centers for Medicare and Medicaid Services (CMS) has extended the enforcement of EPCS-certified E-Prescribing software for Medicare Part D until January 1, 2023. CMS is still urging adoption so that practices can avoid penalties for non-compliance.

Explore Premium Report on e-Prescribing Market @ https://meditechinsights.com/e-prescribing-market/

Competitive Landscape Analysis of e-Prescribing Market
The global e-Prescribing market is marked by the presence of players such as Allscripts, NextGen Healthcare, AdvancedMD, MDToolbox, Practice Fusion, DrFirst, RXNT, Chetu, PrognoCIS, NewCrop, among others.